Panama approves Pfizer COVID-19 booster for high-risk people | Inquirer News

Panama approves Pfizer COVID-19 booster for high-risk people

/ 10:32 AM October 13, 2021

pfizer vaccine

A woman holds a small bottle labeled with a “Coronavirus COVID-19 Vaccine” sticker and a medical syringe in front of displayed Pfizer logo in this illustration taken, October 30, 2020. REUTERS FILE PHOTO

PANAMA CITY — Panama has approved a booster dose of Pfizer Inc’s COVID-19 vaccine for high-risk people, including healthcare workers, bedridden patients, nursing home residents and people over 55, health officials said on Tuesday.

The Central American country has reported 469,440 COVID-19 infections since the start of the pandemic and 7,275 deaths. More than 5.5 million vaccine doses have been administered since January, covering most of the eligible population.

Article continues after this advertisement

“We have decided to begin the process of applying a booster shot to the population with the Pfizer vaccine, starting tomorrow in public and private hospitals,” Health Minister Luis Sucre said.

FEATURED STORIES

The booster shot will be offered to people who received their second dose at least six months before and will target those at high risk of developing complications from the virus, he added.

RELATED STORIES

Article continues after this advertisement

Pfizer COVID vaccine booster dose okayed for Americans aged 65 and older

WHO: No need for booster shots yet except for immunocompromised

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: COVID-19 Vaccine Booster, Health, Panama, Pfizer

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.